Nasdaq new high but up just 0.2% from 2000 peak

The Nasdaq composite made history yesterday, topping its old intraday record high from March 2000. Markets cheered the news. But the sad truth is the Nasdaq is simply back to

Read Full Article

Altera shares jump on talk of Intel bid

Shares of computer chipmaker Altera are up Friday amid renewed speculation about an acquisition by industry giant Intel. Shares of San Jose, Ca.-based Altera were 4.34%% or $2.04 higher, at

Read Full Article

Yellen says Fed on track for first rate hike this year

Federal Reserve Chair Janet Yellen said Friday the central bank remains on track to raise interest rates this year but will do so gradually, adding that she expects the economy

Read Full Article

Google unveils Fi, new wireless service

Google has unveiled its hotly anticipated wireless service Project Fi to prod the telecom industry to make mobile service in the U.S. faster, easier and less expensive. The Internet giant

Read Full Article

Relief rally: Stocks soar on Fed rate news

U.S. stocks rallied sharply after the Federal Reserve ruled out interest rate hikes at next month’s meeting and said it

Read Full Article

New Data on Two Anavex Alzheimer’s Drugs to be Unveiled at AD/PD 2015

NEW YORK, March 19, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing

Read Full Article

Anavex to Participate in Phase 3 Clinical Trials Panel at AD/PD 2015

NEW YORK, March 17, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing

Read Full Article

Athgo Will Host Sixth Global Innovation Forum “Athgothon” at the World Bank in Washington D.C. from August 12-14, 2015

Los Angeles, C.A. – March 16, 2015 – Since its founding in 2002, Athgo International (http://bit.ly/1x6c0n3) has been a major

Read Full Article

Anavex Appoints Epilepsy and Clinical Trial Methodology Expert to Scientific Advisory Board

NEW YORK, March 12, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing

Read Full Article

Anavex to Present at Sigma-1 Receptors Symposium

NEW YORK, March 10, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL) a clinical-stage biopharmaceutical company developing drug

Read Full Article

Calendar

November 2017
M T W T F S S
« Oct    
 12345
6789101112
13141516171819
20212223242526
27282930  

Categories